share_log
  • Headlines
  • Lionco Pharmaceutical Group (603669.SH) released its performance for the first three quarters, with a net loss of 46.89 million yuan.

灵康药业(603669.SH)发布前三季度业绩，净亏损4689万元

Lionco Pharmaceutical Group (603669.SH) released its performance for the first three quarters, with a net loss of 46.89 million yuan.

Zhitong Finance ·  Oct 30 23:09

Lionco Pharmaceutical Group (603669.SH) disclosed the third quarter report for 2024, achieving revenue of 2...

According to the Zhitong Finance APP, Lionco Pharmaceutical Group (603669.SH) disclosed its third quarter report for 2024, with revenue of 0.231 billion yuan, a year-on-year increase of 53.34%; net income attributable to the parent company was a loss of 46.89 million yuan; non-net profit was a loss of 90.86 million yuan; basic earnings per share was -0.07 yuan.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated